Umbrex is pleased to welcome Bernardo Alvares. Bernardo is a healthcare and life sciences strategy consultant with over nine years of experience, including at McKinsey & Company, and a PhD in Immuno-oncology. He has helped top pharma, biotech, and diagnostics companies optimize strategy and operations.
Most recently, Bernardo supported a top-five global pharma in transitioning 300+ global clinical trial teams to a new agile-inspired operating model. He has also advised biotech and diagnostics firms on market entry, go-to-market execution, and commercial strategy for next-generation molecular diagnostics. Bernardo also recently advised a leading US healthcare real-world data provider on their pharma sales strategy to capture new opportunities, working directly with the CEO.
At McKinsey, Bernardo managed strategy projects across healthcare, life sciences, and digital transformation, engaging senior stakeholders to develop high-impact solutions. His expertise spans clinical trials, diagnostics, organizational design, and commercialization strategies.
Bernardo is available for consulting projects in strategy, operations, and commercialization for pharma, biotech, and diagnostics companies.